CSafe and BioLife Solutions, Inc. announce partnership to expand supply chain solutions for the cell and gene therapy market
PR98222
MONROE, Ohio and BOTHELL, Wash., Oct. 11, 2022 /PRNewswire=KYODO JBN/ --
-- CSafe joins BioLife's global partner network of cold chain solution
providers using the evo (R) cold chain management platform
CSafe, one of the largest active and passive temperature-controlled shipping
solutions providers for pharmaceuticals, and BioLife Solutions, Inc. (NASDAQ:
BLFS), a leading supplier of class-defining bioproduction tools and services
for the cell and gene therapy ("CGT") and broader biopharma markets, announced
today a new partnership to provide a combined global service network to support
CGT products, with a focus on enhanced reliability, security and quality.
Photo - https://mma.prnewswire.com/media/1917780/BioLife_Solutions_DV10.jpg
Logo - https://mma.prnewswire.com/media/1917781/CSafe_Logomark_RGB_Logo.jpg
CSafe joins BioLife's global partner network of cold chain solution providers
serving the CGT market. BioLife expects to support 10,000-12,000 evo shipments
of CGT starting materials and manufactured doses over the next 12 months. The
new partnership will provide expanded supply chain options for any CGT product,
at any stage of development, from early clinical-phase trials to global
commercial scale.
CSafe will bring even more of its highly reliable global reach to the CGT
sector through this new alliance. Operating from 50+ service centers worldwide,
the company is a proven, trusted partner for biopharmaceutical manufacturers
seeking to navigate supply chain complexity, with a track record that includes
shipping solutions for six billion doses of a COVID-19 vaccine.
"CSafe is honored to partner with the team at BioLife Solutions, whose range of
CGT bioproduction tools and services is peerless in the market. We are excited
to merge these exceptional tools and services with our expertise in global,
reliable scaled delivery," said CSafe CEO Patrick Schafer. "CGT is hitting its
stride and needs global support. We know how important these therapies are to
patients everywhere, and it's our mission at CSafe to protect every shipment."
"We're excited to work with a global partner with a strong history of
reliability and performance and a deep dedication to innovative therapies,"
said BioLife Solutions CEO Mike Rice. "We have the best LN2 technology and cGMP
storage facilities in the market, in addition to our other world-class CGT
solutions, and we are confident our collaboration with CSafe will extend our
reach and result in even more reliability and real-time service for CGT
partners."
Media Contacts:
April Lynch
+1 937-245-6479
alynch@csafeglobal.com
For BioLife Solutions:
At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com
Investors
LHA Investor Relations
Jody Cain
(310) 691-7100
jcain@lhai.com
About CSafe
CSafe offers the most comprehensive suite of thermal shipping solutions for
pharmaceutical cold chain shipping needs around the world. With a
"patient-first" focus, deep industry expertise and commitment to innovation,
CSafe continues to deliver industry-leading products in both the active and
passive segments. CSafe is the only provider with an end-to-end portfolio
including active and passive bulk air cargo, parcel, cell and gene and
specialty last-mile use cases with the ability to meet the complete range of
pharma cold-chain shipping requirements with industry-leading quality and
reliability. Any size, any duration and any temperature – CSafe is At the Heart
of Your Cold Chain. www.csafeglobal.com
About BioLife Solutions
BioLife Solutions is a leading supplier of class-defining bioproduction tools
and services for the cell and gene therapy and broader biopharma markets. Our
tools portfolio includes our proprietary CryoStor(R) (
)and HypoThermosol(R) (
) biopreservation media for shipping and storage, the ThawSTAR(R) (
) family of automated, water-free thawing products, evo(R) (
) cold chain management system, high capacity cryogenic storage freezers (
), Stirling Ultracold (
)mechanical freezers, SciSafe biologic storage services, and Sexton
Biotechnologies cell processing tools. For more information, please visit
www.biolifesolutions.com, www.scisafe.com, www.stirlingultracold.com, or
www.sextonbio.com and follow BioLife on Twitter (
).
Caution Regarding Forward Looking Statements
Statements in this press release that are not historical facts are
"forward-looking statements" that may involve material risks and uncertainties.
The company wishes to caution readers not to place undue reliance on such
forward-looking statements. All such statements speak only as of the date made.
Source - CSafe
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。
